Video

Hidden Costs for Patients Starting a Specialty Drug Regimen

Author(s):

Lauren Santye, Assistant Editor

Marc O'Connor, COO and chief strategy officer at Curant Health, discusses the out-of-pocket costs that can emerge for patients starting a specialty medication regimen.

Marc O'Connor, COO and chief strategy officer at Curant Health, discusses the out-of-pocket costs that can emerge for patients starting a specialty medication regimen.

Related Videos
Related Content
Cimerli Offers a New, Interchangeable Biosimilar for Ocular Conditions
May 1st 2025

Cimerli Offers a New, Interchangeable Biosimilar for Ocular Conditions

Melissa Garcia, PharmD Candidate Saro Arakelians, PharmD
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
March 31st 2025

Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder

Luke Halpern, Assistant Editor
Health insurance, tax concept on blue background
May 1st 2025

Asembia AXS25: Patients Desire Education and Thorough Resources to Better Navigate Health Plans

Luke Halpern, Assistant Editor
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
February 28th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
US FDA logo on smartphone -- Image credit: Luciano Luppa | stock.adobe.com
April 30th 2025

FDA Approves Nipocalimab-Aahu to Treat Patients With Generalized Myasthenia Gravis

Gillian McGovern, Associate Editor
A scientist in sterile coverall gown pipetting medium or reagents for cell culture experiment in biological safety cabinet. Doing biological research in clean environmental.
April 30th 2025

Asembia AXS25: Cell and Gene Therapies Enter New Phase of Growth in Specialty Pharmacy

Luke Halpern, Assistant Editor